Arcadia Biosciences (RKDA) risk factors, FY2024 10-K

Risks Related to Our Business

1. 01There is substantial doubt about our ability to continue as a going concern, which may hinder our ability to obtain further financing
2. 02Our proposed Exchange transaction with Roosevelt is subject to a number of risks and uncertainties. Failure to complete, or delays in completing, the proposed Exchange transaction with Roosevelt could materially and adversely affect our results of operations, business, financial condition and/or stock price
3. 03We may require additional funding in order to be able to close the Exchange transaction
4. 04We would remain liable for significant transaction costs, including legal, accounting, financial advisory and other costs relating to the Exchange regardless of whether the Exchange is consummated
5. 05If the Exchange is not completed, we would not realize the potential benefits of the Exchange, which could have a negative effect on our results of operations, financial condition, business and stock price
6. 06If the Exchange Agreement is terminated under certain circumstances, the Company may be required to reimburse Roosevelt's expenses up to $500,000 or $750,000, depending on the reasons for the termination
7. 07Statements in this Report on Form 10-K concerning our future plans and operations are dependent on our ability to secure adequate funding and the absence of unexpected delays or adverse developments. We may not be able to secure required funding
8. 08We have a history of significant losses, which we expect to continue, and we may never achieve or maintain profitability
9. 09Arcadia’s gross profit margins on its consumer products may be impacted by a variety of factors, including but not limited to variations, freight costs, pricing, customer requirements, market acceptance rate and promotional support costs
10. 10Competition is intense and if Arcadia is unable to compete effectively, its financial results will suffer
11. 11Arcadia depends on its key personnel and, if it is not able to attract and retain qualified technical and business personnel, it may not be able to continue its business
12. 12replacement of any member of our management team involves significant time and costs and such loss could significantly delay or prevent the achievement of our business objectives
13. 13Arcadia’s business is subject to the risks of security breaches, including cybersecurity incidents
14. 14Arcadia may be required to pay substantial damages as a result of product liability, health and safety, or other similar claims for which insurance coverage is not available
15. 15Unfavorable global economic or political conditions could adversely affect our business, financial condition or results of operations
16. 16Changes to U.S. trade policy, tariff and import/export regulations may adversely affect our operating results

Risks Related to Ownership of Our Common Stock

1. 17Future sales of substantial amounts of Arcadia’s common stock, or the possibility that such sales could occur, could adversely affect the market price of Arcadia’s common stock
2. 18Arcadia’s stock price has been and may continue to be volatile, and you could lose all or part of your investment
3. 19general economic and market conditions and trends
4. 20Arcadia expects its operating results to vary significantly from quarter to quarter, which may cause Arcadia’s stock price to fluctuate widely
5. 21Arcadia’s failure to meet the continued listing requirements of Nasdaq could result in a delisting of its common stock, which could negatively impact the market price and liquidity of its common stock and its ability to access the capital markets
6. 22Certain of our securities issued in prior offerings include a right to receive the Black-Scholes value of the unexercised portion of those securities in the event of a certain kinds of fundamental transactions, which payments, if applicable, could be significant